Showing results (31-40 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|June 21, 2011
Treatment durability, effectiveness, and safety with atazanavir/ritonavir-based HAART regimen in treatment-naïve HIV-infected patientsC Tremblay, B Trottier, A Rachlis, et al.
HIV Clinical Trials|November 3, 2011
A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 studyMary Albrecht, A Lisa Mukherjee, Camlin Tierney, et al.
HIV Clinical Trials|December 23, 2011
Guidelines on the treatment of chronic coinfection by Trypanosoma cruzi and HIV outside endemic areasJosé A Pérez-Molina, Azucena Rodríguez-Guardado, Antonio Soriano, et al.
HIV Clinical Trials|December 23, 2011
Effect of baseline characteristics on the efficacy and safety of once-daily darunavir/ ritonavir in HIV-1-infected, treatment-naïve ARTEMIS patients at week 96Jan Fourie, Jason Flamm, Amalia Rodriguez-French, et al.
HIV Clinical Trials|December 4, 2010
Similar virologic and immunologic efficacy with fosamprenavir boosted with 100 mg or 200 mg of ritonavir in HIV-infected patients: results of the LESS trialCalvin Cohen, Edwin Dejesus, Anthony Lamarca, et al.
HIV Clinical Trials|January 18, 2011
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimenScott M Hammer, Heather Ribaudo, Roland Bassett, et al.
HIV Clinical Trials|April 20, 2010
Effects of etravirine versus placebo on health-related quality of life in treatment-experienced HIV patients as measured by the functional assessment of human immunodeficiency virus infection (FAHI) questionnaire in the DUET trialsDavid Cella, Hélène Gilet, Muriel Viala-Danten, et al.
HIV Clinical Trials|April 20, 2010
A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophyJanet M Raboud, Christina Diong, Andrew Carr, et al.
HIV Clinical Trials|April 20, 2010
Vicriviroc and peripheral neuropathy: results from AIDS Clinical Trials Group 5211Tzu-min Yeh, Scott R Evans, Roy M Gulick, et al.
HIV Clinical Trials|June 15, 2010
Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patientsKathleen E Squires, Benjamin Young, Edwin DeJesus, et al.
Pageof 68